The novel approach of this peptide represents a exciting breakthrough in the management of the condition. Unlike existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide125773.jiliblog.com/98481131/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment